TMDX实时信号 | 通过Getagraph.com最大化利润

购买 3998 min ago

@ $90.72

发出时间: 26 Apr 2024 @ 22:44

回报率: 1.50%

上一信号: Apr 25 - 01:33

上一信号: 出售

回报率: 2.34 %

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

Stats
今日成交量	594 489
平均成交量	741 757
市值	3.01B
EPS	$0 ( 2024-02-26 )
下一个收益日期	( $-0.0600 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-119.58
ATR14	$2.91 (3.16%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-17	Hassanein Waleed H	Sell	4 000	Stock Option (Right to Buy)
2024-04-17	Hassanein Waleed H	Buy	4 000	Common Stock
2024-04-17	Hassanein Waleed H	Sell	4 000	Common Stock
2024-04-10	Hassanein Waleed H	Sell	12 000	Stock Option (Right to Buy)
2024-04-10	Hassanein Waleed H	Buy	12 000	Common Stock

INSIDER POWER
2.74
Last 100 transactions
Buy: 325 751 \| Sell: 307 375

音量相关性

長: -0.10 (neutral)

短: 0.97 (very strong)

Signal:(65) Expect same movement, but be aware

Transmedics Group Inc 相关性

10 最正相关
MMAC	0.929
NSIT	0.919
OBT	0.919
COCO	0.913
PUCKU	0.908
VMD	0.907
QNST	0.906
OSUR	0.903
MCFT	0.902
PFTA	0.9

10 最负相关
VGFC	-0.909
BIOC	-0.909
FRBK	-0.907
ASPU	-0.907
BCBP	-0.898
FSFG	-0.895
CSSE	-0.893
CCCC	-0.89
PAIC	-0.888
LSAQ	-0.888

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Transmedics Group Inc 相关性 - 货币/商品

0.65
( weak )

0.20
( neutral )

0.00
( neutral )

0.37
( neutral )

-0.57
( weak negative )

-0.74
( moderate negative )

Transmedics Group Inc 财务报表

Annual	2023
营收:	$241.62M
毛利润:	$153.99M (63.73 %)
EPS:	$-0.770

FY	2023
营收:	$241.62M
毛利润:	$153.99M (63.73 %)
EPS:	$-0.770

FY	2022
营收:	$93.46M
毛利润:	$65.27M (69.84 %)
EPS:	$-1.230

FY	2021
营收:	$30.26M
毛利润:	$21.16M (69.92 %)
EPS:	$-1.790

Financial Reports:

No articles found.

Transmedics Group Inc

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.